Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000059478-17-000207
Filing Date
2017-11-16
Accepted
2017-11-16 16:37:18
Documents
2
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3138
2 POA poaelililly.txt EX-24 3144
  Complete submission text file 0000059478-17-000207.txt   8055
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37990 | Film No.: 171208401
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations